CUPR

Healthcare Medical Instruments & Supplies

Cuprina Holdings (Cayman) Limited

$2.17

-0.04 -1.81% today

Price History

Not enough data

Key Stats

Market Cap

15.20M

Avg Volume

94,866

EPS

-$1.40

52W High

$14.80

52W Low

$1.45

Div. Yield

0.0%

Valuation

P/B Ratio

1.47

P/S Ratio

304.61

EV/EBITDA

-1.30

EV/Revenue

125.10

Margins

Gross Margin (1.3%)

Operating Margin (10568.3%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

267.4%

Return on Equity

(1569.1%)

Return on Assets

(58.9%)

Liquidity & Leverage

Current Ratio

2.35

Quick Ratio

1.03

Debt / Equity

0.68

Total Cash

3.20M

Total Debt

3.41M

About

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.